There is no evidence of a relation between early changes in tumor size and survival among patients with advanced stage NSCLC. To predict survival in patients with advanced NSCLC, response criteria other than change in lesion size are needed.
No takes yet. Share an insight, caveat, or question.
Birchard et al. (2009) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: